Lorazepam

Product NDC
70518-2799
11-digit product format
705182799
Labeler code
70518
Product ID
70518-2799_b326dcde-d40d-0697-e053-2995a90a05a1
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lorazepam
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA072928
Marketing category
ANDA
Marketing start
2020-06-25
Marketing end
0000-00-00
Substance
LORAZEPAM
Active strength
2 mg/1
Pharmacologic classes
Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2799-02023-09-06C16284748780-1d6a99b39-7dc2-a426-e053-dadaa90af4c2afbcdea1-76a9-4b0a-9dfd-839cbc4c4480
70518-2799-02022-01-28C16284748780-1d6a99b39-7dc2-a426-e053-dadaa90af4c2afbcdea1-76a9-4b0a-9dfd-839cbc4c4480

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2799-07051827990030 TABLET in 1 BLISTER PACK (70518-2799-0) 30 tablet2020-06-250000-00-00NoNoCurrent